Speakers

Jason Acker

Professor, Laboratory Medicine and Pathology

University of Alberta, Canada

Jennifer Adrian

Manager, Cellular Therapy Manufacturing Operations

bluebird bio

Sven Ansorge

Director of Manufacturing

ExCellThera Inc.

Priya Baraniak

Scientist

RoosterBio

Rita Barcia

Executive Director, R&D

Sentien Biotechnologies, Inc, USA (pending final confirmation)

Thomas Bollenbach

Chief Technology Officer

Advanced Regenerative Manufacturing Institute

Sofia Braag

Business Development Principal

University of Massachusetts Medical School

Lars Brandén

CEO, Owner & Founder

LJB Adamantine Science

Jennifer Briggs Braswell, PhD

Chief Administrative Officer

ARMI, BioFab, USA

Robert L. Buchanan

Co-Founder & CEO

Ambulero

Scott Burger

Principal

Advanced Cell & Gene Therapy, USA

Erica Bust

Senior Process Engineer

Juno Therapeutics Inc., USA

Phillip D. Carter

Head of U.S. Market Access

Orchard Therapeutics

Matt Cohen

Partner

Osage University Partners

Michael J. DiBiasio-White, Sr.

Scientist: BioProcess Development/Protein Sciences

Ring Therapeutics

Fabien Dorange

Head of Analytical Development

Genethon

Andrew Espejo

Vector Analytics Lead, CMC Gene Therapy

Vertex Pharmaceuticals (pending final confirmation)

Miguel Forte

CEO

Zelluna Immunotherapy, Norway

Michael Francis

Chief Science Officer & Founder

Embody Inc.

Shinichiro (Shin) Fuse, Ph.D.

Managing Director

MPM Capital

Chris Gemmiti, Ph.D.

Head of Operations

Sentien Biotechnologies Inc.

Jennifer Griffin

VP Industrial Strategy & Investments

Massachusetts Life Science Center

Adam Haskett

Associate Director, External Manufacturing

Kite Pharma

Geoffrey Hodge

Chief Technical Officer

Unum Therapeutics

Barrett J. Nehila

Associate Director, Analytical Development

Torque Therapeutics

Scott Jeffers

Director

UniQure

Jan Jensen

CEO and Founder

Trailhead Biosystems Inc.

George Joseph Christ

Professor of Biomedical Engineering and Orthopaedic Surgery

University of Virginia

Kei Kishimoto

CSO

Selecta Biosciences

Jak Knowles

VP Venture Investments

Bayer

Walter Kowtonuik

Principal

Third Rock Ventures, USA

Thomas Kreil

Vice President, Global Pathogen Safety

Takeda

Andrew L'Huillier

CEO

Revital Therapeutics

Paul Lammers

President & CEO

Triumvira Immunologics

Philip Lee

COO and Co-Founder

Senti Biosciences

Antonio Lee, Ph.D.

CEO & Managing Director

Medipost America Inc.

Michael Lehmicke

Director, Science and Industry Affairs

Alliance for Regenerative Medicine

Sara Levy

CSV & Data integrity Manager

Pluristem Therapeutics Inc.

Kevin W. Mayo

Managing Partner

Venture Genome LLC

Mary Clare McCorry

Director, Technology and Process Development

Advanced Regenerative Manufacturing Institute (ARMI)

David McKenna

Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology

University of Minnesota

Sarah Nikiforow

Asst. Professor, Stem Cell Transplantation Program, Asst. Medical Director, Cell Manipulation Core Facility

Dana-Farber Cancer Institute

Steve Oh

Director Stem Cell Bioprocessing & Institute Professor,

Bioprocessing Technology Institute

Alison Quelch

Director, Talent Acquisition, Global Product Development & Supply

Bristol-Myers Squibb

Mahendra Rao

CEO

panCELLa

Lior Raviv

Vice President

Pluristem Therapeutics Inc.

A Representative

(pending final confirmation)

Juno Therapeutics, USA

Betsy Rezner

Director, Process & Assay Development

Fate Therapeutics Inc.

Andrew Rigoglioso

Associate Director, Talent Acquisition

Flagship Pioneering

Nadine Ritter, Ph.D.

President and Analytical Advisor

Global Biotech Experts, LLC

Michael Roberts

Chief Technology Officer (Europe)

Asklepios BioPharmaceutical, Inc.

Martha Rook

SVP, Manufacturing

Sigilon Therapeutics Inc.

Jon A. Rowley, Ph.D.

Founder & Chief Product Officer

RoosterBio Inc.

Jennifer Royal-Fitch

Lead Recruiter

Gene Therapy Program & The Orphan Disease Center, Univeristy of Pennsylvania

Janelle A. Sabo

Global Head, Clinical Supplies, Systems and Innovation

Eli Lilly Research and Development

Franz Schnetzinger

Director Analytical Development

Gyroscope Therapeutics

Elizabeth Schwarzbach

CBO

New York Stem Cell Foundation

Sha Sha

Postdoc

Massachusetts Institute of Technology

Lara Ionescu Silverman

Senior Director, Research and Development

DiscGenics

Donald Singer

Consultant

formerly, GSK Senior Fellow, Microbiology, Biopharmaceutical GMP Operations, USA

Kalai Sivarajan

Team Leader, CMC

Precision Biosciences (pending final confirmation)

David Smith

Chief Commercial Officer

Healios

Devyn Smith

Chief Strategy Officer and Head of Operations

Sigilon Therapeutics, USA

Alan Smith, Ph.D.

Executive Vice President, Technical Operations

Bellicum Pharmaceuticals

Cristina Stoyanov

CMC Lead

Orchard Therapeutics, USA

Felipe Tapia

Postdoctoral Researcher, Bioprocess Engineering

Max Planck Institute

Nick Timmins

VP Cell Technologies and Entrepreneur in Residence

ArtisanBio, USA

James Dean Vogel

Founder and Director

The BioProcess Institute

Loren Wagner

Head, CAR-T Manufacturing Operations

Bristol-Myers Squibb

Tom Walls

Associate Director Supply Chain

bluebirdbio

Sam Wandsworth

Chief Scientific Officer

Ultragenyx Gene Therapy

Kathy Williams

VP of Quality and Reg Affairs

RoosterBio, Inc., USA

Erik Woods

Co-Founder and Chief Science Officer

Ossium Health, Inc., USA

Mike Zhao

Senior Vice President

MSQ Ventures

Ran Zheng

Chief Technical Officer

Orchard Therapeutics